FedEx Corp (NYSE:FDX) delivered its financial results for the first quarter of fiscal 2026 on Thursday after the bell. Here’s a look at the key details from the report. FDX stock is racing ahead of ...

Over the past few years we’ve seen a bunch of Chinese PC and accessory makers launch affordable network-attached storage (NAS) systems with Intel Alder Lake-N or Twin Lake processors and support for ...

The new iPhone Air is limited to USB 2 transfer speeds and it does not support faster USB 3 transfer speeds like the iPhone 17 Pro models. Apple also didn't update the USB port that it's using for the ...

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...

Nikon has released firmware version 2.00 for its Nikon Z6III full-frame mirrorless camera, and added C2PA compatibility, bird detection, and more. Firmware season is well and truly upon us, and Nikon ...

The second Trump administration has its first federal cybersecurity debacle to deal with. A breach of the United States federal judiciary’s electronic case filing system, discovered around July 4, has ...

Let's say you wanted to place the broadest possible bet on the stock market during the second Trump administration. So, at the closing bell of the New York Stock Exchange at 4 pm Eastern Time on ...

Momentum is building for quantum computing and some observers say that a usable, fault-tolerant quantum system could appear in the next few years. We have written ...

Philippine housing unit prices saw an increase in the first quarter of 2025, albeit at a slower pace, driven by higher prices in the National Capital Region (NCR), the Bangko Sentral ng Pilipinas (BSP ...

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109, United States ...

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study Participants had ...